LIBERTY LANE DEVELOPMENTS LTD

Company number 13528273 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

LIBERTY LANE DEVELOPMENTS LTD - Analysis Report

Company Number: 13528273

Analysis Date: 2025-07-29 15:53 UTC

Financial Health Assessment Report for LIBERTY LANE DEVELOPMENTS LTD
As of 31 July 2024


1. Financial Health Score: D

Explanation:
The company currently exhibits signs of financial distress, indicated by net liabilities and negative working capital, despite support from related parties. This positions the company below a healthy financial state, needing careful management to improve liquidity and solvency.


2. Key Vital Signs:

Metric 2024 Value Interpretation
Net Current Assets (Working Capital) -£49,907 Negative working capital — indicates short-term liquidity stress.
Net Liabilities (Net Assets) -£49,907 Shareholders' deficit, company owes more than it owns.
Stocks (Inventory) £3,232,783 Significant stock holding, increased substantially from prior year.
Trade and Other Debtors £13,036 Relatively low receivables — limited short-term cash inflow.
Cash at Bank and in Hand £12,545 Very low cash balance, signals tight immediate liquidity.
Creditors Due Within One Year £3,308,271 Large short-term liabilities, including significant loans from related parties and directors.
Loans from Connected Companies £1,916,903 Interest-free, no fixed repayment — critical support for solvency.
Loans from Directors £855,000 Interest-free, no fixed repayment — additional external support.
Share Capital £2 Minimal equity base, typical for small private company.
Employees 4 Very small workforce, consistent with a micro/small company.

3. Diagnosis:

LIBERTY LANE DEVELOPMENTS LTD is currently in a state similar to a patient with "circulatory congestion" — the company is burdened with more liabilities than assets, particularly in the short term, causing a liquidity crunch. The negative working capital (-£49,907) reflects an inability to cover short-term debts with current assets, which is a key symptom of financial distress.

The company’s substantial stock holding (£3.23 million) suggests that it is holding significant inventory or development projects, typical for a property development business. However, this stock is tied up capital, not immediately liquid, creating a "stagnant blood flow" scenario where cash is not readily available.

Cash reserves are critically low (£12,545), further intensifying the liquidity strain. However, the presence of significant interest-free loans from connected companies (£1.92 million) and directors (£855,000) acts as a vital lifeline, akin to an external pacemaker keeping the company’s operations alive despite its deficits.

The company’s net liabilities position (-£49,907) signals that its total obligations exceed its total assets, representing a "deficit in vital organ function." This means if external support were withdrawn, the company might face increased risk of insolvency.

Nonetheless, the directors have expressed confidence in ongoing support from parent and connected companies, allowing the business to continue as a going concern for at least the next 12 months.


4. Recommendations:

To improve the company’s financial wellness and move from distress to a healthier state, the following actions are advised:

  • Improve Cash Flow Management:
    Focus on accelerating collections from debtors and optimizing stock turnover to free up cash. Consider selling non-core or slow-moving stock to improve liquidity.

  • Reduce Reliance on Related Party Loans:
    While current loans are interest-free and flexible, this is not sustainable long-term. Develop a plan to gradually repay or restructure these loans into more formal arrangements to improve creditor confidence.

  • Enhance Working Capital Controls:
    Aim to reduce trade creditors or extend payment terms where possible without harming supplier relationships to ease the short-term cash burden.

  • Increase Equity Base:
    Consider capital injection from shareholders or new investors to strengthen the balance sheet and reduce the shareholders’ deficit.

  • Regular Financial Monitoring:
    Implement monthly cash flow forecasts and liquidity monitoring to detect early signs of distress and manage working capital proactively.

  • Strategic Review of Projects:
    Reassess ongoing development projects to ensure they are profitable and aligned with market demand, reducing the risk of inventory obsolescence.


Summary in Medical Analogy:

The company is currently in a "critical care" phase with negative net assets and tight liquidity, relying on "external life support" from related party loans. While this support is stabilizing the situation temporarily, the company must improve its "circulatory system" by freeing cash from inventory and receivables, reducing short-term liabilities, and strengthening equity to restore financial health and avoid the risk of "heart failure" (insolvency).


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.